These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16287786)

  • 61. Epidemiology of genital herpes.
    Kinghorn GR
    J Int Med Res; 1994; 22 Suppl 1():14A-23A. PubMed ID: 8063020
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genital herpes.
    Jungmann E
    Clin Evid; 2005 Jun; (13):1987-2001. PubMed ID: 16135318
    [No Abstract]   [Full Text] [Related]  

  • 63. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
    Sheffield JS; Hill JB; Hollier LM; Laibl VR; Roberts SW; Sanchez PJ; Wendel GD
    Obstet Gynecol; 2006 Jul; 108(1):141-7. PubMed ID: 16816068
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genital shedding of herpes simplex virus among men.
    Wald A; Zeh J; Selke S; Warren T; Ashley R; Corey L
    J Infect Dis; 2002 Oct; 186 Suppl 1():S34-9. PubMed ID: 12353185
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [HSV-1 is also involved].
    Strobel E
    Fortschr Med; 1998 Mar; 116(9):6-8. PubMed ID: 9577069
    [No Abstract]   [Full Text] [Related]  

  • 66. Risk factors for herpes simplex virus transmission to pregnant women: a couples study.
    Baker DA
    Am J Obstet Gynecol; 2005 Dec; 193(6):1887-8. PubMed ID: 16325587
    [No Abstract]   [Full Text] [Related]  

  • 67. Immunobiology of herpes simplex virus (HSV) infections.
    Corey L
    Herpes; 2001 Mar; 8 Suppl 1():1A. PubMed ID: 11867026
    [No Abstract]   [Full Text] [Related]  

  • 68. Aspects of herpes simplex virus: a clinical review.
    Azwa A; Barton SE
    J Fam Plann Reprod Health Care; 2009 Oct; 35(4):237-42. PubMed ID: 19849918
    [No Abstract]   [Full Text] [Related]  

  • 69. [Condom effectiveness to prevent sexually transmitted diseases].
    Vera EG; Orozco HH; Soto SS; Aburto EL
    Ginecol Obstet Mex; 2008 Feb; 76(2):88-96. PubMed ID: 18798401
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial.
    ; Abu-Elyazeed RR; Heineman T; Dubin G; Fourneau M; Leroux-Roels I; Leroux-Roels G; Richardus JH; Ostergaard L; Diez-Domingo J; Poder A; Van Damme P; Romanowski B; Blatter M; Silfverdal SA; Berglund J; Josefsson A; Cunningham AL; Flodmark CE; Tragiannidis A; Dobson S; Olafsson J; Puig-Barbera J; Mendez M; Barton S; Bernstein D; Mares J; Ratner P
    Vaccine; 2013 Dec; 31(51):6136-43. PubMed ID: 23850416
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence and association between herpes simplex virus types 1 and 2-specific antibodies in attendees at a sexually transmitted disease clinic.
    Roest RW; van der Meijden WI; van Dijk G; Groen J; Mulder PG; Verjans GM; Osterhaus AD
    Int J Epidemiol; 2001 Jun; 30(3):580-8. PubMed ID: 11416087
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Control of STDs--the role of prophylactic vaccines against herpes simplex virus.
    Stanberry LR
    Sex Transm Infect; 1998 Dec; 74(6):391-4. PubMed ID: 10195045
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Incidence and prevalence of herpes simplex virus infections in adolescent women.
    Fife KH; Fortenberry JD; Ofner S; Katz BP; Morrow RA; Orr DP
    Sex Transm Dis; 2006 Jul; 33(7):441-4. PubMed ID: 16540882
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling.
    Gottlieb SL; Douglas JM; Foster M; Schmid DS; Newman DR; Baron AE; Bolan G; Iatesta M; Malotte CK; Zenilman J; Fishbein M; Peterman TA; Kamb ML;
    J Infect Dis; 2004 Sep; 190(6):1059-67. PubMed ID: 15319854
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genital shedding of herpes simplex virus type 2 in childbearing-aged and pregnant women living in Gabon.
    Ozouaki F; Ndjoyi-Mbiguino A; Legoff J; Onas IN; Kendjo E; Si-Mohamed A; Mbopi-Kéou FX; Malkin JE; Bélec L
    Int J STD AIDS; 2006 Feb; 17(2):124-7. PubMed ID: 16464276
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Coping strategies and behavioural changes following a genital herpes diagnosis among an urban sample of underserved Midwestern women.
    Davis A; Roth A; Brand JE; Zimet GD; Van Der Pol B
    Int J STD AIDS; 2016 Mar; 27(3):207-12. PubMed ID: 25792549
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A model of the transmission and control of genital herpes.
    Newton EA; Kuder JM
    Sex Transm Dis; 2000 Aug; 27(7):363-70. PubMed ID: 10949427
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Case-crossover analysis of condom use and herpes simplex virus type 2 acquisition.
    Stanaway JD; Wald A; Martin ET; Gottlieb SL; Magaret AS
    Sex Transm Dis; 2012 May; 39(5):388-93. PubMed ID: 22504606
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reaffirmed USPSTF Recommendation Against Serologic Screening for Genital Herpes: Empowering Clinicians and Reducing Potential Harm.
    Yeung H; Sheth AN; Collins LF
    JAMA Dermatol; 2023 Apr; 159(4):371-373. PubMed ID: 36787146
    [No Abstract]   [Full Text] [Related]  

  • 80. Herpes Simplex Virus Type 1 Genital Ulcer Disease at a Tertiary Care Hospital in North India.
    Brijwal M; Rawre J; Dhawan B; Khanna N; Choudhary A; Dar L
    Clin Infect Dis; 2019 May; 68(10):1783-1784. PubMed ID: 30388201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.